Abstract:Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expression in patients suspected of having XLA who were referred from the Taiwan Foundation of Rare Disorders (TFRD).Methods: Patients with recurrent bacterial infections in the first 2 years of life, serum IgG/A/M below 2 standard deviations of the normal range, and ≦2% CD19+B cells were enrolled during the period of 2004–2019. The frequency of infections, pathogens, B-lymphocyte subsets, and family pedigree were recorded. Peripheral blood samples were sent to our institute for BTK expression and genetic analysis.Results: Nineteen (from 16 families) out of 29 patients had BTK mutations, including 7 missense mutations, 7 splicing mutations, 1 nonsense mutation, 2 huge deletions, and 2 nucleotide deletions. Six novel mutations were detected: c.504G>T [p.K168N], c.895-2A>G [p.Del K290 fs 23*], c.910T>G [p.F304V], c.1132T>C [p.T334H], c.1562A>T [p.D521V], and c.1957delG [Del p.D653 fs plus 45 a.a.]. All patients with BTK mutations had obviously decreased BTK expressions. Pseudomonas sepsis developed in 14 patients and led to both Shanghai fever and recurrent hemophagocytic lymphohistiocytosis (HLH). Recurrent sinopulmonary infections and bronchiectasis occurred in 11 patients. One patient died of pseudomonas sepsis and another died of hepatocellular carcinoma before receiving optimal treatment. Two patients with contiguous gene deletion syndrome (CGS) encompassing the TIMM8A/DDP1 gene presented with early-onset progressive post-lingual sensorineural Deafness, gradual Dystonia, and Optic Neuronopathy syndrome (DDON) or Mohr-Tranebjaerg syndrome (MTS).Conclusion: Pseudomonas sepsis was more common (74%) than recurrent sinopulmonary infections in Taiwanese XLA patients, and related to Shanghai fever and recurrent HLH, both of which were prevented by regular immunoglobulin infusions. Approximately 10% of patients belonged to CGS involving the TIMM8A/DDP1 gene and presented with the DDON/MTS phenotype in need of aggressive psychomotor therapy.

[Detection of Bruton's tyrosine kinase gene mutations and clinical analysis of 6 patients with X-linked agammaglobulinemia].

Identification of Four Novel Mutations in BTK from Six Chinese Families with X-linked Agammaglobulinemia.

A Novel Bruton Tyrosine Kinase Gene Variation Was Found in an Adult with X‐linked Agammaglobulinemia During Blood Cross‐matching Prior to Surgical Operation

Clinical Characteristics and Genetic Profiles of 174 Patients with X-linked Agammaglobulinemia: Report from Shanghai, China (2000-2015).

Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia

Novel Deletion Mutation in Bruton's Tyrosine Kinase Results in X-linked Agammaglobulinemia: A Case Report.

The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages

Bruton’s Agammaglobulinemia in an Adult Male Due to a Novel Mutation: a Case Report

Atypical Manifestation of X-linked Agammaglobulinemia - the Importance of Genetic Testing

Preimplantation genetic diagnosis for X-linked agammaglobulinemia: a case report.

Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia

Outcomes of X-Linked Agammaglobulinaemia Patients

X-linked Agammaglobulinemia in Children

Juvenile Idiopathic Arthritis In X-Linked Agammaglobulinemia With A Novel In-Frame Deletion: A Case Report And Functional Analysis

Dysregulation of Toll-Like Receptor Signaling-Associated Gene Expression in X-Linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression

Progress in Biological Characteristics of Bruton's Agammaglobulinemia Tyrosine Kinase

Identification of Two Novel Mutations in Patients with X-Linked Primary Immunodeficiencies

An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked Agammaglobulinemia.

Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia

Treatment for X -Linked Agammaglobulinemia with Allogeneic Umbilical Cord Blood Stem Cell Transplantation from HLA-Matched Sibling Confirmed Healthy Through Prenatal Diagnosis

Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis